Prizes and awards recipients<\/h1><\/div><\/div><\/div>\n<\/div><\/div><\/div><\/div><\/div>\n<\/div><\/div>\n<\/div>\n\nCongratulations to recipients of the IAS 2021 prizes, awards, research grants and fellowships.<\/h2><\/div><\/div><\/div>
\nRead more about the prizes and awards and past awardees here<\/a>.<\/p>\n<\/div><\/section><\/p>\n<\/div><\/div><\/div><\/div>\n<\/div>\n\nLange\/van Tongeren Prizes (IAS-ANRS) for Young Investigators \u2013 Annual Prizes<\/h2><\/div><\/div><\/div>\nTrack A: Basic science
\nBasiel Cole<\/strong>, Belgium, “In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of residual viremia and rebound viruses”<\/p>\nTrack B: Clinical science
\nAyokunle Olanrewaju<\/strong>, United States, “A rapid enzymatic assay for selective detection of HIV drugs that indicate long-term and short-term PrEP adherence”<\/p>\nTrack C: Prevention science
\nJohanna Chapin-Bardales<\/strong>, United States, “Gonorrhea and chlamydia prevalence and associated characteristics among transgender women in 5 U.S. cities, NHBS, 2019”<\/p>\nTrack D: Implementation science
\nThomas Carpino<\/strong>, United States, “HIV risk behaviors among those with and without viral load suppression: findings from population surveys from four African countries”<\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/div><\/div><\/div>\nIAS\/Abivax Research-for-Cure Academy Fellowship Prize \u2013 Annual Prize<\/h2><\/div><\/div><\/div>\nMaria Paximadis<\/strong>, South Africa, for her active engagement and valuable input to the collaborative research projects at the Research-for-Cure Academy. During the 2020 academy, Maria presented her research on looking for signs of replicant-competent virus in the South African child.<\/p>\n\u00a0<\/strong><\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/div><\/div><\/div>\nIAS\/MSD Prize for Research in HIV Prevention<\/h2><\/div><\/div><\/div>\nIsabella Young<\/strong>, United States, “Next generation 3D-printed intravaginal rings for prevention of HIV and unplanned pregnancy”<\/p>\nCarlos Fernando Caceres<\/strong>, Peru, “Early predictors of seroconversion among enrolees in a PrEP program in Brazil, Mexico and Peru \u2013 the IMPREP Demonstration study”<\/p>\nBrendan L. Harney<\/strong>, Australia, “Hepatitis C virus reinfection incidence among gay, bisexual, and other men who have sex with men living with HIV before and after the availability of direct acting antivirals in Australia”<\/p>\nRachel\u00a0 Miller<\/strong>, Canada, “SARS-CoV-2 lockdown associated with expansion of HIV transmission clusters among key populations”<\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/div><\/div><\/div>\nIAS\/ANRS Dominique Dormont Prize<\/h2><\/div><\/div><\/div>\nChrist-Dominique Ngassaki-Yoka<\/strong>, Canada, “The circadian clock machinery regulates HIV transcription in CD4+ T cells”<\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/div><\/div><\/div>\nCIPHER Grant Programme \u2013 Annual programme<\/h2><\/div><\/div><\/div>\nThe grantees were selected to respond to CIPHER\u2019s strategic focus for the 2021 round of the Grant Programme. This was on\u00a0service delivery for HIV and related co-infections<\/strong>\u00a0for paediatric and adolescent populations in resource-limited settings, including research on:<\/p>\n\n- The\u00a0impact of the COVID-19 pandemic<\/strong>on service delivery for HIV and related co-infections<\/li>\n
- Community interventions<\/strong>to improve outcomes along the HIV cascade.<\/li>\n<\/ul>\n
The CIPHER Grant Programme is made possible with the support of Founding Sponsor ViiV Healthcare.<\/p>\n<\/div><\/section><\/div>
The three grantees are:<\/p>\n
\n- Maganizo Brave Chagomerana<\/strong>, Malawi, Paediatric HIV \u2013 \u201cFeasibility pilot to characterize a differentiated service delivery model for HIV early infant diagnosis in high-risk mother-infant pairs\u201d. Read more\u00a0here<\/a>.<\/li>\n
- Pauline Mary Amuge<\/strong>, Uganda, Paediatric HIV \u2013 \u201cDifferentiated delivery of tuberculosis preventive treatment (TPT) within existing health facility and community HIV care models to improve TPT uptake and completion among children and adolescents living with HIV in Uganda following the COVID-19 pandemic\u201d. Read more\u00a0here<\/a>.<\/li>\n
- Francis Ateba Ndongo<\/strong>, Cameroon, Adolescent HIV \u2013 \u201cMental health of adolescents living with HIV in Cameroon: evaluation of a psychological and social intervention model\u201d (Francophone application, original title: \u201cSant\u00e9 mentale des adolescents vivant avec le VIH au Cameroun : \u00e9valuation d\u2019un mod\u00e8le d\u2019intervention psychologique et sociale\u201d). Read more\u00a0here<\/a>.<\/li>\n<\/ul>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"yoast_head":"\n
Prizes and awards recipients - IAS 2021<\/title>\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n
Congratulations to recipients of the IAS 2021 prizes, awards, research grants and fellowships.<\/h2><\/div><\/div><\/div>
\nRead more about the prizes and awards and past awardees here<\/a>.<\/p>\n<\/div><\/section><\/p>\n<\/div><\/div><\/div><\/div>\n<\/div>\n\nLange\/van Tongeren Prizes (IAS-ANRS) for Young Investigators \u2013 Annual Prizes<\/h2><\/div><\/div><\/div>\nTrack A: Basic science
\nBasiel Cole<\/strong>, Belgium, “In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of residual viremia and rebound viruses”<\/p>\nTrack B: Clinical science
\nAyokunle Olanrewaju<\/strong>, United States, “A rapid enzymatic assay for selective detection of HIV drugs that indicate long-term and short-term PrEP adherence”<\/p>\nTrack C: Prevention science
\nJohanna Chapin-Bardales<\/strong>, United States, “Gonorrhea and chlamydia prevalence and associated characteristics among transgender women in 5 U.S. cities, NHBS, 2019”<\/p>\nTrack D: Implementation science
\nThomas Carpino<\/strong>, United States, “HIV risk behaviors among those with and without viral load suppression: findings from population surveys from four African countries”<\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/div><\/div><\/div>\nIAS\/Abivax Research-for-Cure Academy Fellowship Prize \u2013 Annual Prize<\/h2><\/div><\/div><\/div>\nMaria Paximadis<\/strong>, South Africa, for her active engagement and valuable input to the collaborative research projects at the Research-for-Cure Academy. During the 2020 academy, Maria presented her research on looking for signs of replicant-competent virus in the South African child.<\/p>\n\u00a0<\/strong><\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/div><\/div><\/div>\nIAS\/MSD Prize for Research in HIV Prevention<\/h2><\/div><\/div><\/div>\nIsabella Young<\/strong>, United States, “Next generation 3D-printed intravaginal rings for prevention of HIV and unplanned pregnancy”<\/p>\nCarlos Fernando Caceres<\/strong>, Peru, “Early predictors of seroconversion among enrolees in a PrEP program in Brazil, Mexico and Peru \u2013 the IMPREP Demonstration study”<\/p>\nBrendan L. Harney<\/strong>, Australia, “Hepatitis C virus reinfection incidence among gay, bisexual, and other men who have sex with men living with HIV before and after the availability of direct acting antivirals in Australia”<\/p>\nRachel\u00a0 Miller<\/strong>, Canada, “SARS-CoV-2 lockdown associated with expansion of HIV transmission clusters among key populations”<\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/div><\/div><\/div>\nIAS\/ANRS Dominique Dormont Prize<\/h2><\/div><\/div><\/div>\nChrist-Dominique Ngassaki-Yoka<\/strong>, Canada, “The circadian clock machinery regulates HIV transcription in CD4+ T cells”<\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/div><\/div><\/div>\nCIPHER Grant Programme \u2013 Annual programme<\/h2><\/div><\/div><\/div>\nThe grantees were selected to respond to CIPHER\u2019s strategic focus for the 2021 round of the Grant Programme. This was on\u00a0service delivery for HIV and related co-infections<\/strong>\u00a0for paediatric and adolescent populations in resource-limited settings, including research on:<\/p>\n\n- The\u00a0impact of the COVID-19 pandemic<\/strong>on service delivery for HIV and related co-infections<\/li>\n
- Community interventions<\/strong>to improve outcomes along the HIV cascade.<\/li>\n<\/ul>\n
The CIPHER Grant Programme is made possible with the support of Founding Sponsor ViiV Healthcare.<\/p>\n<\/div><\/section><\/div>
The three grantees are:<\/p>\n
\n- Maganizo Brave Chagomerana<\/strong>, Malawi, Paediatric HIV \u2013 \u201cFeasibility pilot to characterize a differentiated service delivery model for HIV early infant diagnosis in high-risk mother-infant pairs\u201d. Read more\u00a0here<\/a>.<\/li>\n
- Pauline Mary Amuge<\/strong>, Uganda, Paediatric HIV \u2013 \u201cDifferentiated delivery of tuberculosis preventive treatment (TPT) within existing health facility and community HIV care models to improve TPT uptake and completion among children and adolescents living with HIV in Uganda following the COVID-19 pandemic\u201d. Read more\u00a0here<\/a>.<\/li>\n
- Francis Ateba Ndongo<\/strong>, Cameroon, Adolescent HIV \u2013 \u201cMental health of adolescents living with HIV in Cameroon: evaluation of a psychological and social intervention model\u201d (Francophone application, original title: \u201cSant\u00e9 mentale des adolescents vivant avec le VIH au Cameroun : \u00e9valuation d\u2019un mod\u00e8le d\u2019intervention psychologique et sociale\u201d). Read more\u00a0here<\/a>.<\/li>\n<\/ul>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"yoast_head":"\n
Prizes and awards recipients - IAS 2021<\/title>\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n
\n
Read more about the prizes and awards and past awardees here<\/a>.<\/p>\n<\/div><\/section><\/p>\n<\/div><\/div> Track A: Basic science Track B: Clinical science Track C: Prevention science Track D: Implementation science Maria Paximadis<\/strong>, South Africa, for her active engagement and valuable input to the collaborative research projects at the Research-for-Cure Academy. During the 2020 academy, Maria presented her research on looking for signs of replicant-competent virus in the South African child.<\/p>\n \u00a0<\/strong><\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/div><\/div><\/div> Isabella Young<\/strong>, United States, “Next generation 3D-printed intravaginal rings for prevention of HIV and unplanned pregnancy”<\/p>\n Carlos Fernando Caceres<\/strong>, Peru, “Early predictors of seroconversion among enrolees in a PrEP program in Brazil, Mexico and Peru \u2013 the IMPREP Demonstration study”<\/p>\n Brendan L. Harney<\/strong>, Australia, “Hepatitis C virus reinfection incidence among gay, bisexual, and other men who have sex with men living with HIV before and after the availability of direct acting antivirals in Australia”<\/p>\n Rachel\u00a0 Miller<\/strong>, Canada, “SARS-CoV-2 lockdown associated with expansion of HIV transmission clusters among key populations”<\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/div><\/div><\/div> Christ-Dominique Ngassaki-Yoka<\/strong>, Canada, “The circadian clock machinery regulates HIV transcription in CD4+ T cells”<\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/div><\/div><\/div> The grantees were selected to respond to CIPHER\u2019s strategic focus for the 2021 round of the Grant Programme. This was on\u00a0service delivery for HIV and related co-infections<\/strong>\u00a0for paediatric and adolescent populations in resource-limited settings, including research on:<\/p>\n The CIPHER Grant Programme is made possible with the support of Founding Sponsor ViiV Healthcare.<\/p>\n<\/div><\/section><\/div> The three grantees are:<\/p>\nLange\/van Tongeren Prizes (IAS-ANRS) for Young Investigators \u2013 Annual Prizes<\/h2>
\nBasiel Cole<\/strong>, Belgium, “In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of residual viremia and rebound viruses”<\/p>\n
\nAyokunle Olanrewaju<\/strong>, United States, “A rapid enzymatic assay for selective detection of HIV drugs that indicate long-term and short-term PrEP adherence”<\/p>\n
\nJohanna Chapin-Bardales<\/strong>, United States, “Gonorrhea and chlamydia prevalence and associated characteristics among transgender women in 5 U.S. cities, NHBS, 2019”<\/p>\n
\nThomas Carpino<\/strong>, United States, “HIV risk behaviors among those with and without viral load suppression: findings from population surveys from four African countries”<\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/div><\/div><\/div>IAS\/Abivax Research-for-Cure Academy Fellowship Prize \u2013 Annual Prize<\/h2>
IAS\/MSD Prize for Research in HIV Prevention<\/h2>
IAS\/ANRS Dominique Dormont Prize<\/h2>
CIPHER Grant Programme \u2013 Annual programme<\/h2>
\n
\n